Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;28(3):409-416.
doi: 10.1111/1744-9987.14097. Epub 2023 Dec 20.

Peritoneal dialysis in Herzegovina, Federation of Bosnia and Herzegovina: 18 years of experience from our center

Fila Raguž  1 , Monika Tomić  1 , Andrea Stojčić  1 , Manuel Tipurić  2 , Mile Volarić  3 , Sanja Bevanda  4
Affiliations

Peritoneal dialysis in Herzegovina, Federation of Bosnia and Herzegovina: 18 years of experience from our center

Fila Raguž et al. Ther Apher Dial. 2024 Jun.

Abstract

Introduction: Due to treatment of end-stage-renal-disease (ESRD), continuous peritoneal dialysis (CAPD) is used in 11% of cases and is associated with several PD-associated infections.

Methods: Clinical data on 71 patients with CAPD were evaluated in addition to exit site infections and episodes of acute peritonitis (AP).

Results: There were 39 men and 32 women. Average age was 61 years when we began CAPD and average time spent on CAPD program was 3.35 years. Illness that dominantly caused ESRD was diabetes (23 patients). Exit site infection was mostly caused by S epidermidis-MRSE and AP was most commonly caused by Staphylococcus sp. group. Most common cause of death was cardiovascular disease. At the end of this study, 9 patients were alive and still on CAPD, 10 were transplanted, 15 switched to HD and 36 died.

Conclusion: Optimal prevention measures and treatment of infectious complications in CAPD is necessary for better treatment possibilities.

Keywords: acute peritonitis; continuous ambulatory peritoneal dialysis; end stage renal disease; exit site infection.

PubMed Disclaimer

References

REFERENCES

    1. Diabetes mellitus on peritoneal dialysis: the Turkey Multicenter Clinic Study. Ren Fail. 2014;36:149–153.
    1. Nishina M, Yanagi H, Kakuta T, Endoh M, Fukagawa M, Takagi A. A 10‐year retrospective cohort study on the risk factors for peritoneal dialysis‐related peritonitis: a single‐center study at Tokai University Hospital. Clin Exp Nephrol. 2014;18(4):649–654.
    1. Cho Y, Bello AK, Levin A, Lunney M, Osman MA, Ye F, et al. Peritoneal dialysis use and practice patterns: an international survey study. Am J Kidney Dis. 2021;77:315–325.
    1. Karopadi AN, Mason G, Rettore E, Ronco C. Cost of peritoneal dialysis and haemodialysis across the world. Nephrol Dial Transplant. 2013;28:2553–2569.
    1. Cho Y, Johnson DW. Peritoneal dialysis‐related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis. 2014;64(2):278–289.

LinkOut - more resources